Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raphamin for Prevention of Chronic Bacterial Cystitis Recurrences
NCT06284265Phase 3Active, not recruiting
- Sponsor
- Materia Medica Holding
- Start
- Oct 2023
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
A Phase 3 trial of raphamin in bacterial cystitis, sponsored by Materia Medica Holding. Started Oct 2023; status: active, not recruiting.
02
Drugs
raphamin
03
Conditions
bacterial cystitis
Beyond the preview
Go deeper on NCT06284265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06284265.